NYU Dentistry Study Finds Evidence That Protein MCP-1 May Determine Bone Loss Responses to Parathyroid Hormone

Image by JOSE LUIS CALVO MARTIN & JOSE ENRIQUE GARCIA-MAURIÑO MUZQUIZ/ ISTOCK/ GETTY IMAGES PLUS

In a study published in Scientific Reports, New York University College of Dentistry (NYU Dentistry) researchers investigating the catabolic effect of parathyroid hormone (PTH) in hyperparathyroidism (HPT) showed that monocyte chemoattractant protein-1 (MCP-1) is required for catabolic responses to PTH. HTP is a condition in which an abnormally high concentration of PTH in the blood accelerates bone loss.

NYU Dentistry reports, researchers focused on the role of MCP-1 in PTH-induced osteoclast formation. The team recreated the hyperparathyroid state in mice by constantly elevating their hyperparathyroid levels. Over a two-week period, they continuously infused female wild-type and MCP-1 knockout mice with human PTH. They showed that the ability of PTH to increase osteoclast formation in vitro is markedly impaired in cells from MCP-1 knockout mice and concluded that MCP-1 is an important chemokine, or signaling protein, in PTH-induced osteoclast formation and bone resorption.

The findings support the possibility that MCP-1 could be a marker for how PTH works in humans with hyperparathyroidism, as elevated serum MCP-1 has been shown to be correlated with elevated serum PTH levels in women.

The study, “Catabolic Effects of Human PTH (1–34) on Bone: Requirement of Monocyte Chemoattractant Protein-1 in Murine Model of Hyperparathyroidism,” was published in November.

No Responses

Add a Comment

Your email address will not be published. Required fields are marked *

Palmero Healthcare Contest Brings Smiles to Practices and Patients Everywhere

After 30 years of bringing smiles to patients, Palmero Healthcare’s Happy...

Kettenbach Named TOP 100 Innovator for 2018

At the fifth German Mittelstands-Summit on June 29 in Ludwigsburg, Germany, Kettenbach...

Young Innovations Acquires Johnson-Promident

Young Innovations, a leading global manufacturer and distributor of dental products,...

NYU Dentistry’s Nicole Scheff Receives NIH Grant

Research Could Spur Development of Novel Oral Cancer Therapeutic Strategies That...

LANAP and LAPIP Protocols: Laser Gum Disease Protocols

Over 50% of US adults have gum disease.  Offer your patients...

IRIS HD USB 3.0 Intraoral Camera

Experience the Clarity in High Definition The new IRIS HD USB...

A New Adhesive/Primer Ideal for Indirect Restorations

At BISCO, adhesion is our passion. BISCO prides itself on developing...

KDZ Bruxer® Aesthetic

Bring the strength of full-contour zirconia into the facial zone with...